Michael A Cucciare1,2,3, Andrea L Jamison4, Ann S Combs5, Gauri Joshi5, Ramsey C Cheung6,7, Catherine Rongey8,9, Joe Huggins10, Keith Humphreys5,11. 1. a Center for Mental Healthcare and Outcomes Research , Central Arkansas Veterans Affairs Healthcare System , North Little Rock , AR , USA. 2. b Veterans Affairs South Central Mental Illness Research, Education, and Clinical Center, Central Arkansas Veterans Healthcare System , North Little Rock , AR , USA. 3. c Department of Psychiatry , University of Arkansas for Medical Sciences , Little Rock , AR , USA. 4. d National Center for Posttraumatic Stress Disorder , Veterans Affairs Palo Alto Health Care System , Menlo Park , CA , USA. 5. e Center for Innovation to Implementation , Veterans Affairs Palo Alto Health Care System , Menlo Park , CA , USA. 6. f Division of Gastroenterology and Hepatology , Veterans Affairs Palo Alto Health Care System , Palo Alto , CA , USA. 7. g Division of Gastroenterology and Hepatology , Stanford University , Stanford , CA , USA. 8. h San Francisco Veterans Affairs Health Care System , San Francisco , CA , USA. 9. i Department of Medicine , University of California San Francisco , San Francisco , CA , USA. 10. j Veterans Affairs (Rocky Mountain) Mental Illness Research, Education, and Clinical Center , Veterans Affairs Eastern Colorado Health Care System , Denver , CO , USA. 11. k Department of Psychiatry , Stanford University , Stanford , CA , USA.
Abstract
OBJECTIVE: This study adapted an existing computer-delivered brief alcohol intervention (cBAI) for use in Veterans with the hepatitis C virus (HCV) and examined its acceptability and feasibility in this patient population. METHODS: A four-stage model consisting of initial pilot testing, qualitative interviews with key stakeholders, development of a beta version of the cBAI, and usability testing was used to achieve the study objectives. RESULTS: In-depth interviews gathered feedback for modifying the cBAI, including adding HCV-related content such as the health effects of alcohol on liver functioning, immune system functioning, and management of HCV, a preference for concepts to be displayed through "newer looking" graphics, and limiting the use of text to convey key concepts. Results from usability testing indicated that the modified cBAI was acceptable and feasible for use in this patient population. CONCLUSIONS: The development model used in this study is effective for gathering actionable feedback that can inform the development of a cBAI and can result in the development of an acceptable and feasible intervention for use in this population. Findings also have implications for developing computer-delivered interventions targeting behavior change more broadly.
OBJECTIVE: This study adapted an existing computer-delivered brief alcohol intervention (cBAI) for use in Veterans with the hepatitis C virus (HCV) and examined its acceptability and feasibility in this patient population. METHODS: A four-stage model consisting of initial pilot testing, qualitative interviews with key stakeholders, development of a beta version of the cBAI, and usability testing was used to achieve the study objectives. RESULTS: In-depth interviews gathered feedback for modifying the cBAI, including adding HCV-related content such as the health effects of alcohol on liver functioning, immune system functioning, and management of HCV, a preference for concepts to be displayed through "newer looking" graphics, and limiting the use of text to convey key concepts. Results from usability testing indicated that the modified cBAI was acceptable and feasible for use in this patient population. CONCLUSIONS: The development model used in this study is effective for gathering actionable feedback that can inform the development of a cBAI and can result in the development of an acceptable and feasible intervention for use in this population. Findings also have implications for developing computer-delivered interventions targeting behavior change more broadly.
Authors: Risha Irvin; Geetanjali Chander; Kathleen M Ward; Sean Manogue; Oluwaseun Falade-Nwulia; Juhi Moon; Catherine G Sutcliffe; Sherilyn Brinkley; Taryn Haselhuhn; Stephanie Katz; Kayla Herne; Lilian Arteaga; David L Thomas; Shruti H Mehta; Mark S Sulkowski Journal: J Viral Hepat Date: 2020-01-07 Impact factor: 3.728
Authors: Traci H Abraham; Kathy Marchant-Miros; Michael B McCarther; Michelle G Craske; Geoffrey M Curran; Lisa K Kearney; Carolyn Greene; Jan A Lindsay; Michael A Cucciare Journal: JMIR Ment Health Date: 2018-08-22